Previous studies have shown that SIX1, a transcription factor, enhances the expansion of phenotypic and functional CSCs in breast cancer [17], colorectal cancer [18] esophageal cancer [19] and phenotypic CSCs in pancreatic cancers [20]. Here, SIX1 is linked to breast carcinoma.